Heartflow Q1 revenue rises 41% and lifts 2026 outlook

Heartflow

14/05/2026 21:11

Overview

US AI cardiac diagnostics firm's Q1 revenue rose 41% yr/yr, driven by higher U.S. FFR(CT) volume

Gross margin improved to 80.2%, aided by AI efficiency and higher case volume

Company raised 2026 revenue guidance to 29%-32% growth yr/yr

Outlook

Heartflow raises 2026 revenue guidance to $228 mln-$232 mln, up from $218 mln-$222 mln

Company lifts 2026 non-GAAP gross margin outlook to approximately 81% from 80%-81%

Result Drivers

HIGHER U.S. FFR(CT) VOLUME - Co said revenue growth was primarily due to increased U.S. FFR(CT) case volume

AI EFFICIENCY INITIATIVES - Co said gross margin expansion was driven by improved production team productivity from AI efficiency initiatives

INCREASED INVESTMENT - Co said higher operating expenses reflected increased investment in sales personnel, technology, and clinical research

Company press release: ID:nGNXbzlnLq

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
$52.59 mln
Q1 Net Income
-$27.38 mln
Q1 Gross Profit
$42.16 mln
Q1 Income from Operations
-$29.50 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Heartflow Inc is $38.00, about 21.8% above its May 13 closing price of $31.20

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)